| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |